J. David Enloe Jr - Mar 15, 2022 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Chief Executive Officer, Director
Signature
Ryan D Lake, attorney-in-fact
Stock symbol
SCTL
Transactions as of
Mar 15, 2022
Transactions value $
$1,004
Form type
4
Date filed
3/17/2022, 05:33 PM
Previous filing
Feb 17, 2022
Next filing
Apr 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Purchase $1K +512 +0.1% $1.96 525K Mar 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.